Caravel Bio is a biotechnology company developing an integrated platform for protein discovery and engineering.
Caravel Bio has raised $7.8M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
Caravel Bio's investors include National Science Foundation, Pioneer Fund, 2048 Ventures, The Venture Collective, Portland Seed Fund.
Caravel Bio is headquartered in Portland, United States.
Caravel Bio is a biotechnology company developing an integrated platform for protein discovery and engineering.
Caravel Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Caravel Bio — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/caravel-bio. Accessed September 29, 2026.
VCBacked. (2025). Caravel Bio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/caravel-bio
{{cite web |title=Caravel Bio — Funding & Investors |url=https://www.vcbacked.co/company/caravel-bio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated